Pharmacist Training and Patient-Centered Diabetes Care
Published Online: Friday, May 2, 2014
In this video, Starlin Haydon-Greatting, MS, BSPharm, FAPHA, director of clinical programs at the Illinois Pharmacists Association, discusses the range of education and training that prepares pharmacists to play a role in patient-centered diabetes care.
This interview was recorded at the American Journal of Managed Care's live meeting on Patient-Centered Diabetes Care, held in Princeton, NJ.
The FDA today approved dulaglutide (Trulicity), a once-weekly injectable therapy indicated to improve blood sugar control in adults with type 2 diabetes.
Combined with bolus insulin aspart (NovoLog), insulin degludec (Tresiba) improves long-term glycemic control in children and adolescents with type 1 diabetes.
Results show pharmacists and other healthcare providers can work together to successfully empower patients disproportionately affected by diabetes to achieve improved clinical outcomes.